Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease.
Saved in:
| Title: | Edaravone dexborneol alleviates pericyte-mediated fibrosis depositing extracellular matrix through TGF-β1/IL-11 in cerebral small vessel disease. |
|---|---|
| Authors: | Duan, Qingrui1,2 (AUTHOR), Liu, Zhiyang1,2 (AUTHOR), Xing, Yuxuan1,2 (AUTHOR), Huang, Haifeng1,2 (AUTHOR), Zhu, Lin1,2 (AUTHOR), Liu, Jiaxuan1,2 (AUTHOR), He, Peikun1,2 (AUTHOR), Ma, Guixian1,2 (AUTHOR), Zhang, Yuhu1,2 (AUTHOR), Nie, Kun1,2 (AUTHOR) niekun@gdph.org.cn, Gao, Yuyuan1,2 (AUTHOR) gaoyuyuan@gdph.org.cn, Wang, Lijuan1,2 (AUTHOR) wanglijuan@gdph.org.cn |
| Source: | Journal of Translational Medicine. 2/5/2025, Vol. 23 Issue 1, p1-22. 22p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 14795876 |
|---|---|
| DOI: | 10.1186/s12967-025-06157-3 |